#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12212	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2098	573.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1675	1675	T	639	T	621	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12212	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2098	573.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	711	C	694	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3627	611.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1792	1792	A	678	A	670	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3627	611.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2426	2426	C	700	C,A	680,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3627	611.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2500	2500	A	721	A	704	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22388	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3627	611.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3052	3052	C	678	C	664	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1710	folP	855	855	99.88	folP.l15.c4.ctg.1	1531	110.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1026	1028	AGC	169;166;164	A;G;C	167;164;159	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4950	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3438	142.3	0	.	p	.	0	D95A	NONSYN	283	285	GAC	663	665	GCC	145;145;145	G;C,A;C	143;143,1;144	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4950	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3438	142.3	1	SNP	p	S91F	1	.	.	271	273	TTC	651	653	TTC	154;154;152	T;T,C;C	153;151,1;150	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1466	mtrR	633	633	99.06	mtrR.l6.c4.ctg.1	1411	102.8	0	.	p	.	0	A39T	NONSYN	115	117	GCC	447	449	ACC	153;155;154	A;C;C	142;151;153	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1466	mtrR	633	633	99.06	mtrR.l6.c4.ctg.1	1411	102.8	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	645	647	CAC	156;159;157	C;A,C;C	153;152,1;155	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1466	mtrR	633	633	99.06	mtrR.l6.c4.ctg.1	1411	102.8	0	.	p	.	0	A127fs	FSHIFT	379	379	G	711	711	G	174	G	167	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1466	mtrR	633	633	99.06	mtrR.l6.c4.ctg.1	1411	102.8	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	166;164;168	G;G;C	164;162;166	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	868	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1108	77.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3980	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3123	126.1	0	.	p	.	0	S87N	NONSYN	259	261	AGT	721	723	AAT	168;168;168	A,C;A,G;T	160,1;157,1;161	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3980	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3123	126.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1765	1767	GCA	181;180;180	G;C;A,T	177;167;160,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3980	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3123	126.1	1	SNP	p	D86N	0	.	.	256	258	GAC	718	720	GAC	167;168;167	G;A;C	161;155;159	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3980	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3123	126.1	1	SNP	p	S88P	0	.	.	262	264	TCC	724	726	TCC	167;168;169	T;C;C	159;155;163	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3514	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2585	134.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1552	1554	GGC	173;169;169	G;G;C,G	171;169;164,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1316	1318	GCA	169;170;175	G;C;A,C	168;168;169,1	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1319	1321	ATC	176;176;176	A;T;C,G	173;175;173,1	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1331	1333	GTG	172;172;174	G,A;T,C,G;G,C	170,1;167,1,1;172,1	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1331	1333	GTG	172;172;174	G,A;T,C,G;G,C	170,1;167,1,1;172,1	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1835	1837	ACC	147;147;147	A,T;C,T;C	141,1;143,1;141	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1889	1891	GCG	152;150;150	G;C,G;G	146;132,2;145	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1889	1891	GCG	152;150;150	G;C,G;G	146;132,2;145	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2012	2014	GGT	138;134;133	G;G;T	135;133;131	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2021	2023	GGC	110;106;105	G;G;C	109;105;102	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3334	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2623	125.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2039	2041	CCG	84;86;89	C,G;C;G,C	72,1;74;78,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4886	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3177	152.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1640	1642	CCG	180;181;178	C;C,T;G	163;177,1;166	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2024	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1851	107.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	571	571	C	148	C,G	135,2	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	T18M	NONSYN	52	54	ACG	310	312	ATG	158;155;153	A;T;G	156;152;151	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	G46D	NONSYN	136	138	GGC	394	396	GAC	146;148;148	G;A,C;C	141;142,1;147	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	E48G	NONSYN	142	144	GAA	400	402	GGA	155;158;162	G;G;A	151;154;157	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	V75I	NONSYN	223	225	GTT	481	483	ATT	173;172;172	A;T;T	170;167;170	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	T89S	NONSYN	265	267	ACC	523	525	AGC	145;144;145	A;G;C	144;143;143	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	V98I	NONSYN	292	294	GTC	550	552	ATC	135;130;132	A;T;C	130;124;128	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	.	MULTIPLE	358	359	AA	615	616	CG	140;139	C;G,C	139;131,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	.	MULTIPLE	361	362	GA	618	620	CAG	138;140;141	C;A;G,A	133;134;134,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	N122K	NONSYN	364	366	AAC	622	624	AAA	142;145;148	A,C;A;A	136,1;145;148	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	649	651	TAT	161;160;162	T;A;T	157;156;158	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	N134E	NONSYN	400	402	AAT	658	660	GAG	164;163;164	G;A;G	161;157;160	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	V135L	NONSYN	403	405	GTG	661	663	CTT	167;170;171	C;T;T	163;166;167	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	G140K	NONSYN	418	420	GGA	676	678	AAA	152;152;152	A;A;A	150;151;149	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	K143E	NONSYN	427	429	AAA	685	687	GAA	148;147;149	G;A;A	146;145;147	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	V151A	NONSYN	451	453	GTA	709	711	GCA	150;154;156	G,A;C;A	145,1;151;152	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	T213S	NONSYN	637	639	ACA	895	897	TCA	167;169;170	T,G;C,T;A,G	166,1;164,1;166,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1015	1017	CAA	169;169;170	C;A;A	167;168;170	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	.	INDELS	760	762	ACA	1019	1023	ATCAA	169;167;169;167;168	A;T;C;A;A	169;164;168;167;168	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	.	INDELS	763	764	TG	1026	1028	AGT	168;166;165	A;G;T	168;166;163	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1033	1035	GAT	167;168;170	G;A;T	166;168;170	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	T269S	NONSYN	805	807	ACC	1069	1071	AGC	154;154;150	A;G,C;C	151;150,1;146	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1141	1143	AGT	190;189;187	A;G;T,G	188;186;184,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1147	1149	GAC	190;191;192	G;A;C	187;186;188	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1150	1152	TAC	193;196;199	T;A;C	189;189;197	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	1	SNP	p	G120K	1	.	.	358	360	AAG	615	617	CGG	140;139;139	C;G,C;G,T	139;131,1;136,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	1	SNP	p	D121N	0	.	.	361	363	GAC	618	621	CGC	138;141;140	C;G,A;C	133;134,1;134	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2120	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1448	144.2	1	SNP	p	A121D	1	.	.	361	363	GAC	618	621	CGC	138;141;140	C;G,A;C	133;134,1;134	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8442	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4802	174.4	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1955	1957	AAT	192;192;192	A,C,T;A;T	188,1,1;190;190	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	990	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1060	91.7	1	SNP	p	V57M	1	.	.	169	171	ATG	617	619	ATG	190;191;189	A;T;G	184;185;186	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	M177T	NONSYN	529	531	ATG	941	943	ACG	360;360;361	A;C;G	354;357;356	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	962	964	GAC	342;339;342	G;A;C	341;332;339	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	T190M	NONSYN	568	570	ACG	980	982	ATG	335;334;336	A;T;G	335;331;336	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	L194S	NONSYN	580	582	TTA	992	994	TCA	344;346;344	T,G;C,T;ATT,AT	340,1;343,1;336,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1037	1039	CAG	387;392;392	C;A;G	385;390;391	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1058	1060	CTT	364;363;358	C,T;T;T	362,1;363;357	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1079	1081	AGT	340;343;347	A;G;T	337;339;336	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1148	1150	CCG	354;353;354	C;C;G,A	347;345;346,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1250	1252	TCG	360;361;369	T;C;G	356;356;360	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1421	1423	AAA	240;235;232	A;A;A	238;233;230	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1424	1426	AAG	229;225;232	A;A;G	227;223;230	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1439	1441	CAC	218;217;220	C;A;C	218;208;219	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1478	1480	GAA	234;229;234	G;A;A	232;228;233	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1556	1558	ACG	148;148;146	A;C,T;G	147;147,1;146	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1607	1609	ATT	183;184;184	A;T;T	183;184;183	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1610	1612	AGT	185;184;182	A;G;T	184;183;180	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1649	1651	CTA	199;198;200	C;T;A,G	196;195;197,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1691	1693	AAT	148;148;147	A;A;T	148;147;144	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1760	1762	TCA	197;197;201	T;C;A,G	195;197;198,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1784	1786	ATG	213;214;215	A;T;G	212;212;213	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2078	2080	ACC	458;453;451	A;C;C	443;443;441	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8258	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2645	308.5	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2174	2176	GAA	413;410;415	G;A;A	409;405;410	.	Tetracycline resistance
